TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26010029

Group type: EXPERIMENTAL
Intervention: AccuCirc
Number of subjects: 150

Group type: COMPARATOR
Intervention: Mogen clamp
Number of subjects: 150
Study: 25702400

Group type: EXPERIMENTAL
Intervention: Allapinine (ALP) (1.5 mg/kg/d)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Quinidine bisulphate (QUIN) (15 mg/kg/d)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Allapinine (ALP)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Quinidine bisulphate (QUIN)
Number of subjects: 73
Study: 22215166

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 2010

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2010
Study: 18922712

Group type: EXPERIMENTAL
Intervention: Multiple injections of <0.5 ml 1% polidocanol foam
Number of subjects: 107

Group type: COMPARATOR
Intervention: Few injections of >0.5 ml 1% polidocanol foam
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 107
Study: 17278196

Group type: EXPERIMENTAL
Intervention: Tegaserod (6 mg b.i.d.)
Number of subjects: 607

Group type: COMPARATOR
Intervention: Placebo (b.i.d.)
Number of subjects: 607
Study: 15361727

Group type: EXPERIMENTAL
Intervention: Clarithromycin 30 mg/kg/day b.i.d. for 5 days
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Clarithromycin 15 mg/kg/day b.i.d. for 5 days
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate 43.8/6.2 mg/kg/day b.i.d. for 5 days
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Penicillin V 30 mg/kg/day 3 times a day for 10 days
Number of subjects: 626
Study: 11603222

Group type: EXPERIMENTAL
Intervention: 100 mg/day of progesterone
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 300 mg/day of progesterone
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 400 mg/day of progesterone
Number of subjects: 107

Group type: COMPARATOR
Intervention: Estrogen only (control)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Late secretory endometrium from 19 premenopausal women
Number of subjects: 107
Study: 9658047

Group type: EXPERIMENTAL
Intervention: Electrical stimulus to the superficial peroneal nerve during walking
Number of subjects: 0
Study: 8080744

Group type: EXPERIMENTAL
Intervention: Breast cancer screening (7 years)
Number of subjects: 22294

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 22294
Study: 2787887

Group type: EXPERIMENTAL
Intervention: Mestranol (30 micrograms/day)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 178687

Group type: EXPERIMENTAL
Intervention: Chronic E administration (ethinyl estradiol 0.5 mg/day for 7 to 70 days)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: iv administration of E (bolus injection of 25 mg conjugated estrogens, USP)
Number of subjects: 6

Group type: COMPARATOR
Intervention: iv administration of normal saline
Number of subjects: 6
Study: 30879954

Group type: EXPERIMENTAL
Intervention: Primene (n=14)
Number of subjects: 94

Group type: COMPARATOR
Intervention: TrophAmine (n=21)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 94
Study: 27771320

Group type: EXPERIMENTAL
Intervention: Sterile water injections (SWI)
Number of subjects: 9
Study: 25825373

Group type: EXPERIMENTAL
Intervention: Conventional alar base cinching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified alar base cinching
Number of subjects: 60
Study: 23760911

Group type: EXPERIMENTAL
Intervention: nicardipine
Number of subjects: 54

Group type: COMPARATOR
Intervention: labetalol
Number of subjects: 54
Study: 21196807

Group type: EXPERIMENTAL
Intervention: Community-based program for PD with DSI
Number of subjects: 123

Group type: COMPARATOR
Intervention: Long-term residential program for PD with DSI
Number of subjects: 123
Study: 18714500

Group type: EXPERIMENTAL
Intervention: Systane treatment
Number of subjects: 0
Study: 17174180

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 436
Study: 14519795

Group type: EXPERIMENTAL
Intervention: High carbohydrate (CHO) diet (% of energy: CHO, 58.3; fat, 25.8)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High monounsaturated fatty acid (MUFA) diet (% of energy: CHO, 44.7; fat, 40.1; MUFA, 22.5)
Number of subjects: 65

Group type: COMPARATOR
Intervention: High MUFA diet
Number of subjects: 65
Study: 11117099

Group type: EXPERIMENTAL
Intervention: Feature-present condition (familiar letter paired with a novel letter containing a distinguishing element)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Feature-absent condition (familiar letter paired with a novel letter with one element removed)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Familiarization time of 20 seconds
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Familiarization time of 30 seconds
Number of subjects: 60
Study: 8781870

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms, four puffs)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1290334

Group type: EXPERIMENTAL
Intervention: Multiload-Cu375 (MLCu375)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiload-Cu250 (MLCu250)
Number of subjects: 0
Study: 6611385

Group type: EXPERIMENTAL
Intervention: Trimethoprim and sulfamethoxazole
Number of subjects: 67
Study: 30712496

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion lignocaine
Number of subjects: 19
Study: 26656722

Group type: EXPERIMENTAL
Intervention: Tele-thrombolysis (IV rt-PA administration in ER)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care (immediate transfer to stroke center)
Number of subjects: 49
Study: 27062408

Group type: EXPERIMENTAL
Intervention: K-877 0.025 mg BID
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: K-877 0.05 mg BID
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: K-877 0.1 mg BID
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: K-877 0.2 mg BID
Number of subjects: 224

Group type: COMPARATOR
Intervention: Fenofibrate 100 mg QD
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: K-877
Number of subjects: 224
Study: 25052587

Group type: EXPERIMENTAL
Intervention: TV64.6 Gy
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: TV43.7 Gy
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: BMI at the start of RT
Number of subjects: 232
Study: 21862226

Group type: EXPERIMENTAL
Intervention: 24 IU oxytocin (OT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 48 IU oxytocin (OT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19155056

Group type: EXPERIMENTAL
Intervention: 10 mg warfarin initiation nomogram
Number of subjects: 414
Study: 17355503

Group type: EXPERIMENTAL
Intervention: Nitrate-mediated dilatation in migraineurs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nitrate-mediated dilatation in nonmigraineurs (control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Flow-mediated dilatation in migraineurs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Flow-mediated dilatation in nonmigraineurs (control)
Number of subjects: 50
Study: 15021442

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study: 11160543

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (two 7000‐microg retinol equivalent doses)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study: 9758015

Group type: EXPERIMENTAL
Intervention: Brief alcohol prevention intervention
Number of subjects: 211

Group type: COMPARATOR
Intervention: Minimal control materials
Number of subjects: 211
Study: 8155452

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg and PCA containing morphine
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Droperidol 0.05 mg mg‐1 of morphine in PCA
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (placebo and PCA containing morphine)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Droperidol PCA group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Droperidol bolus group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 3422519

Group type: EXPERIMENTAL
Intervention: Cefotetan (2 gm IV every 12 hours)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cefoxitin (2 gm IV every six to eight hours)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 53
Study: 31373077

Group type: EXPERIMENTAL
Intervention: Cannula subcision (18 gauge cannula)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Needle subcision (27 gauge needle)
Number of subjects: 100
Study: 29684092

Group type: EXPERIMENTAL
Intervention: Short cycle therapy (SCT; 5 days on, 2 days off ART)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Continuous therapy (CT)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Short cycle therapy (SCT)
Number of subjects: 199
Study: 26460894

Group type: EXPERIMENTAL
Intervention: Competence and Adherence Scale for Cognitive Behavioral Therapy (CAS‐CBT)
Number of subjects: 182
Study: 25578377

Group type: EXPERIMENTAL
Intervention: Anthracycline-based chemotherapy (6 cycles)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Docetaxel followed by eprirubicin/docetaxel (3 cycles each)
Number of subjects: 283
Study: 24434090

Group type: EXPERIMENTAL
Intervention: Once-daily dosing
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fast titration
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Stimulant-naive patients
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Twice-daily dosing
Number of subjects: 25
Study: 20625120

Group type: COMPARATOR
Intervention: Control (Arm A): four cycles of mitomycin (8 mg/m(2) on day 1)/vindesine (3 mg/m(2) on days 1, 8)/cisplatin (80 mg/m(2) on day 1) plus TRT 60 Gy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental (Arm B): weekly irinotecan (20 mg/m(2))/carboplatin (AUC 2) for 6 weeks plus TRT 60 Gy, followed by two courses of irinotecan (50 mg/m(2) on days 1, 8)/carboplatin (AUC 5 on day 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental (Arm C): weekly paclitaxel (40 mg/m(2))/carboplatin (AUC 2) for 6 weeks plus TRT 60 Gy, followed by two courses of paclitaxel (200 mg/m(2) on day 1)/carboplatin (AUC 5 on day 1)
Number of subjects: 0
Study: 17330626

Group type: EXPERIMENTAL
Intervention: Metronidazole topical gel 0.75%
Number of subjects: 582
Study: 15025849

Group type: EXPERIMENTAL
Intervention: PDRN ointment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (non-adherent gauzes and bulky gauzes with cloramine solution)
Number of subjects: 40
Study: 11448900

Group type: EXPERIMENTAL
Intervention: Melanoma vaccine (40 microg, bound to alum as an adjuvant)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo vaccine (human albumin, bound to alum as an adjuvant)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Melanoma vaccine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo vaccine
Number of subjects: 38
Study: 9697011

Group type: EXPERIMENTAL
Intervention: Therapist-led condition (TL; n = 16)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Partial self-help condition (PSH; n = 19)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Structured self-help condition (SH; n = 15)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Waiting list control condition (WL; n = 11)
Number of subjects: 61
Study: 8275733

Group type: EXPERIMENTAL
Intervention: 167-ml chamber device (Device A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 700-ml chamber device (Device B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: nonchamber device (Device C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: nonchamber device (Device D)
Number of subjects: 48
Study: 3050853

Group type: EXPERIMENTAL
Intervention: 25 micrograms dose of H. influenzae type b PRP vaccine
Number of subjects: 223

Group type: COMPARATOR
Intervention: 12.5 micrograms dose of H. influenzae type b PRP vaccine (used in 1974)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Comparison to 1974 vaccinations
Number of subjects: 223
Study: 17894054

Group type: EXPERIMENTAL
Intervention: Higher dosage of pizotyline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lower dosage of pizotyline
Number of subjects: 100
Study: 28829670

Group type: EXPERIMENTAL
Intervention: PKP combined with aclasta (zoledronic acid)
Number of subjects: 104

Group type: COMPARATOR
Intervention: PKP (control group)
Number of subjects: 104
Study: 27225761

Group type: EXPERIMENTAL
Intervention: Baseline catecholamine levels indexed by pupil diameter
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Norepinephrine transporter blocker atomoxetine
Number of subjects: 48
Study: 25773565

Group type: EXPERIMENTAL
Intervention: Global rating of improvement
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Incontinence-specific HRQOL instrument
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Generic preference-based HRQOL outcome
Number of subjects: 52
Study: 23864720

Group type: EXPERIMENTAL
Intervention: MCI patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 20180694

Group type: EXPERIMENTAL
Intervention: Sootshekhar Rasa (250 mg) plus Sitopaladi Churna (400 mg) daily for 90 days
Number of subjects: 1322

Group type: EXPERIMENTAL
Intervention: Iron and folic acid tablet for 90 days
Number of subjects: 1322

Group type: COMPARATOR
Intervention: Control group (starch)
Number of subjects: 1322
Study: 17560819

Group type: EXPERIMENTAL
Intervention: Nurse follow-up intervention (home visits every 4th month for 2 years, total 7 visits)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Nurse follow-up intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 16996826

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose followed by 10 mg daily
Number of subjects: 13000

Group type: COMPARATOR
Intervention: Clopidogrel 300 mg loading dose followed by 75 mg daily
Number of subjects: 13000

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 13000

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13000
Study: 15851823

Group type: EXPERIMENTAL
Intervention: Parkinson's disease patients
Number of subjects: 12

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study: 11211168

Group type: EXPERIMENTAL
Intervention: Vitamin E (1000 IU for 3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetic cohort
Number of subjects: 0
Study: 9772136

Group type: EXPERIMENTAL
Intervention: Vitamin A (VA) supplementation (210 μmol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7996292

Group type: EXPERIMENTAL
Intervention: Decision analysis model (n = 43)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Usual clinical work-up for pulmonary embolism (control group, n = 41)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Decision analysis model
Number of subjects: 84
Study: 3050300

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 15343351

Group type: EXPERIMENTAL
Intervention: Oral sucrose
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 32
Study: 30281924

Group type: EXPERIMENTAL
Intervention: Fentanyl (300 μg oral dose)
Number of subjects: 35
Study: 28968304

Group type: EXPERIMENTAL
Intervention: Telephone dispatcher-assisted CPR (T-CPR) in untrained guided group (n=32)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Telephone dispatcher-assisted CPR (T-CPR) in trained guided group (n=30)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No T-CPR in untrained nonguided group (n=27)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No T-CPR in trained nonguided group (n=26)
Number of subjects: 115
Study: 24745630

Group type: EXPERIMENTAL
Intervention: 8-mm long TISAD/TAD
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6-mm long TISAD/TAD
Number of subjects: 0
Study: 23163910

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: linagliptin 10 mg
Number of subjects: 540

Group type: COMPARATOR
Intervention: linagliptin 5 mg and 10 mg
Number of subjects: 540
Study: 21450089

Group type: EXPERIMENTAL
Intervention: Referral to a vocational rehabilitation (VR) service
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (no formal employment support)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral to a VR service
Number of subjects: 0
Study: 19251137

Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (AcrySof toric IOL) implantation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paired opposite clear corneal incisions (OCCIs) with spherical IOL implantation
Number of subjects: 40
Study: 16452736

Group type: EXPERIMENTAL
Intervention: Oral alendronate at a dosage of 10 mg/day for six months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no alendronate)
Number of subjects: 60
Study: 15212653

Group type: EXPERIMENTAL
Intervention: GH replacement therapy (0.017 mg/kg/week for 1 month, then 0.033 mg/kg/week)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: GH replacement therapy (open study after 6 months)
Number of subjects: 31
Study: 11301961

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study: 9215240

Group type: EXPERIMENTAL
Intervention: Injections of peanut extract (0.5 ml of 1:100 wt/vol peanut extract)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Injections of peanut extract
Number of subjects: 12
Study: 8305355

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg t.d.s.
Number of subjects: 192

Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg t.d.s.
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 192
Study: 3566820

Group type: EXPERIMENTAL
Intervention: Inservice training program for public health nurses
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (nurses not in the experimental group)
Number of subjects: 158
Study: 31539818

Group type: EXPERIMENTAL
Intervention: 20% AA group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 35% AA group
Number of subjects: 16
Study: 30938751

Group type: EXPERIMENTAL
Intervention: Interactive trust-enhanced e-consent
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Interactive-only e-consent
Number of subjects: 734

Group type: COMPARATOR
Intervention: Standard e-consent (no interactivity, no trust enhancement)
Number of subjects: 734
Study: 28577171

Group type: EXPERIMENTAL
Intervention: MiniArc (SIMS)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Monarc (SMUS)
Number of subjects: 193
Study: 26578315

Group type: EXPERIMENTAL
Intervention: High cognitive load (N-Back task)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low cognitive load (N-Back task)
Number of subjects: 20
Study: 25632625

Group type: EXPERIMENTAL
Intervention: Balloon assisted Valsalva maneuver (PBAV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Valsalva maneuver (CV)
Number of subjects: 40
Study: 22549085

Group type: EXPERIMENTAL
Intervention: Throwers Ten (TT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Keiser Pneumatic (KP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Plyometric (PLY)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 19745828

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 35

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 35
Study: 19759992

Group type: EXPERIMENTAL
Intervention: Interdisciplinary allied health education course for allied health students
Number of subjects: 1300000
Study: 15891523

Group type: EXPERIMENTAL
Intervention: Trichloroethylene exposure
Number of subjects: 0
Study: 11641293

Group type: EXPERIMENTAL
Intervention: Soy protein supplement to increase protein intake to 25% energy
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Psyllium supplement to provide an additional 12 g soluble fiber/d
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both protein and fiber supplements
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low-protein, low-fiber diet (control)
Number of subjects: 41
Study: 9677603

Group type: EXPERIMENTAL
Intervention: Low birth weight (LBW) children
Number of subjects: 2470

Group type: EXPERIMENTAL
Intervention: Term low birth weight (LBW) children
Number of subjects: 2470
Study: 7977173

Group type: COMPARATOR
Intervention: Ondansentron (5‐HT3) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ondansentron (5‐HT3) plus alprazolam (APZ)
Number of subjects: 0
Study: 2686456

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptives (ethinyl estradiol and levonorgestrel)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptives (ethinyl estradiol and norethindrone)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptives (all formulations)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (nonhormonal methods)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: All triphasic oral contraceptives
Number of subjects: 130
Study: 4931488

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Phetharbital
Number of subjects: 11
Study: 30051179

Group type: EXPERIMENTAL
Intervention: sCD163
Number of subjects: 1541

Group type: EXPERIMENTAL
Intervention: MIF
Number of subjects: 1541

Group type: EXPERIMENTAL
Intervention: sIL-2R
Number of subjects: 1541

Group type: EXPERIMENTAL
Intervention: ALCAM
Number of subjects: 1541

Group type: EXPERIMENTAL
Intervention: Granulysin
Number of subjects: 1541

Group type: COMPARATOR
Intervention: Darbepoetin alfa treatment
Number of subjects: 1541
Study: 28676236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Treatment (nifedipine controlled-release tablet)
Number of subjects: 80